Sue Siegel leads two of General Electric’s (GE) growth and innovation initiatives as Chief Executive Officer, GE Ventures & Healthymagination. GE Ventures invests in and partners with the start-up ecosystem across healthcare, energy, software, advanced manufacturing and lighting. Healthymagination harnesses innovation and partnership inside and outside GE to improve the quality, access and affordability of healthcare.
Sue has more than 30- years of experience in corporate and venture capital. Previously, as a financial venture capitalist, Sue led investments in personalized medicine, digital health and life sciences at Silicon Valley-based Mohr Davidow Ventures. Before venture capital, she drove strategy and technology development as well as new market growth at Bio-Rad, DuPont, Amersham and Affymetrix. As President and a Board Member of Affymetrix, Sue led the company’s transformation from a pre-revenue start up to a global, multibillion dollar market cap genomics leader.
Sue has served on over two dozen private and public corporate boards. She currently serves on the boards of the National Venture Capital Association, Stanford Hospital Board’s IT Committee, Harvard Partners’ Innovation Advisory Board, the Cleveland Clinic’s Innovation Council, University of California’s Innovation Council and serves on the Executive Committee of Santa Clara University’s Center for Science, Technology, and Society’s Advisory Board. She is a President’s Circle member of the National Academies of Science, a member of YPO-WPO, Women Corporate Directors, and a Henry Crown Fellow of the Aspen Institute. In the bestselling business book: Multipliers: How The Best Leaders Make Everyone Smarter, Sue was a featured “Multiplier.” She was recognized as one of “The 100 Most Influential Women in Silicon Valley.”